Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21811055 | HLA-B*35 | primary ovarian insufficiency | Japanese | NA | NA | unclassified | |
| association of primary ovarian insufficiency with a specific human leukocyte antigen haplotype (a*24:02-c*03:03-b*35:01) in japanese women. | |||||||
| 21332809 | HLA (HLA) | grafting skin | NA | NA | NA | unclassified | |
| four weeks after grafting, skin biopsies were harvested to take hematoxylin and eosin staining and immunohistochemistry staining of melan-a and hla-abc. | |||||||
| 30529060 | HLA-B*15 | chronic renal insufficiency | NA | allopurinol | NA | unclassified | |
| among the 153 hla-b*58:01 carriers with chronic renal insufficiency (cri), the incidence of scars doubled to 6.5% and further increased to 40%, 30%, and 37.5% in the presence of hla-b75, dr13 homozygosity, or dr14, respectively. | |||||||
| 30529060 | HLA-B*58 | chronic renal insufficiency | NA | allopurinol | NA | unclassified | |
| among the 153 hla-b*58:01 carriers with chronic renal insufficiency (cri), the incidence of scars doubled to 6.5% and further increased to 40%, 30%, and 37.5% in the presence of hla-b75, dr13 homozygosity, or dr14, respectively. | |||||||
| 30529060 | HLA-DRB1*13 | chronic renal insufficiency | NA | allopurinol | NA | unclassified | |
| among the 153 hla-b*58:01 carriers with chronic renal insufficiency (cri), the incidence of scars doubled to 6.5% and further increased to 40%, 30%, and 37.5% in the presence of hla-b75, dr13 homozygosity, or dr14, respectively. | |||||||
| 30529060 | HLA-DRB1*14 | chronic renal insufficiency | NA | allopurinol | NA | unclassified | |
| among the 153 hla-b*58:01 carriers with chronic renal insufficiency (cri), the incidence of scars doubled to 6.5% and further increased to 40%, 30%, and 37.5% in the presence of hla-b75, dr13 homozygosity, or dr14, respectively. | |||||||
| 30580048 | HLA-B*58 | allopurinol | Korean | febuxostat | NA | unclassified | |
| NA | |||||||
| 30580048 | HLA-B*58 | allopurinol | Korean | febuxostat | NA | unclassified | |
| NA | |||||||
| 21426257 | HLA MATCHED (HLA-MATCHED) | vaccine-preventable diseases | NA | NA | NA | unclassified | |
| although early vaccination to protect against vaccine-preventable diseases is desirable, there are still limited data on whether this approach is efficacious in patient groups whose immune recovery differs from recipients of an unmodified hla-matched sibling transplant. | |||||||
| 25628751 | HLA-DR (HLA-DR) | hip fracture | NA | NA | NA | positive | |
| additionally, activated cd69(+ve) (p = .005) and hladr(+ve) (p < .001) cd8 t cells, were also higher in depressed hip fracture patients compared to healthy controls. | |||||||
Copyright 2024